- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on CD19 Expressing Malignancies
Total 1639 results
-
St. Jude Children's Research HospitalGenzyme, a Sanofi CompanyCompleted
-
Dana-Farber Cancer InstituteMiltenyi Biomedicine GmbHCompletedHematologic MalignanciesUnited States
-
Instituto de Investigacion Sanitaria La FeUnknown
-
Indiana University School of MedicineGenzyme, a Sanofi CompanyCompletedHematologic MalignanciesUnited States
-
Emory UniversityCompletedHematologic Diseases | Hematologic MalignanciesUnited States
-
Emory UniversityCompleted
-
Nantes University HospitalCompleted
-
University of LiegeKU Leuven; Amgen; Vrije Universiteit BrusselCompletedHematological MalignanciesBelgium
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; AmgenCompletedHematologic MalignanciesUnited States
-
Hospital Clinic of BarcelonaUnknown
-
St. Louis Children's HospitalUnknown
-
Hrain Biotechnology Co., Ltd.Shanghai Zhongshan HospitalRecruitingFollicular Lymphoma | Diffuse Large B-cell Lymphoma | CD19-positiveChina
-
Incyte CorporationRecruitingB-Cell MalignanciesUnited States, Spain, Belgium, Italy, Japan, France, United Kingdom, Israel, Turkey, Norway, Korea, Republic of, Czechia, Sweden, Austria, Poland, Hungary, Denmark
-
Shanghai Longyao Biotechnology Inc., Ltd.UnknownThe Clinical Study of CD19 UCAR-T Cells in Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL)B-cell Acute Lymphoblastic Leukemia (B-ALL) | Safety and Efficacy of CD19 UCAR-T CellsChina
-
Charite University, Berlin, GermanyUniversity of LeipzigUnknownAcute Myeloid Leukemias | Advanced Hematological Malignancies | Indication for Allogeneic Stem Cell Transplantation | no HLA-identical Donor AvailableGermany
-
Universiti Putra MalaysiaCentral Sugars Refinery Sdn Bhd, MalaysiaTerminatedMetabolic Syndrome | Cardiometabolic Risk | Gene ExpressionMalaysia
-
HutchmedRecruitingHematological MalignanciesChina
-
Miltenyi Biomedicine GmbHCity of Hope Comprehensive Cancer CenterNot yet recruitingHematological Malignancies
-
Smart Immune SASRecruiting
-
University of RochesterRecruitingHematologic MalignanciesUnited States
-
Smart Immune SASRecruitingHematological MalignanciesUnited States
-
Zhejiang UniversityYake Biotechnology Ltd.Recruiting
-
Ascentage Pharma Group Inc.RecruitingHematologic MalignanciesUnited States, Australia
-
PfizerActive, not recruitingNon-small-cell Lung Cancer | Advanced MalignanciesChina, Korea, Republic of, Taiwan, Japan, Russian Federation, Ukraine
-
Gilead SciencesTerminatedHematological MalignanciesUnited States, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingHematological MalignanciesUnited States, Canada, Brazil, Chile, Denmark, France, Germany, Hungary, Israel, Italy, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
-
Julie-An M. TalanoMiltenyi Biotec, Inc.Active, not recruitingHematologic MalignanciesUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingHematological MalignanciesChina
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development; Dutch...CompletedHematological MalignanciesNetherlands
-
NYU Langone HealthTerminated
-
M.D. Anderson Cancer CenterCompletedHematological MalignanciesUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedHematological MalignanciesUnited States
-
Seoul National University HospitalMinistry of Health, Republic of Korea; The Korea Health Technology R&D Project...UnknownHematologic MalignanciesKorea, Republic of
-
Yale UniversityHospira, now a wholly owned subsidiary of PfizerCompleted
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedHematologic MalignanciesUnited States
-
Baylor College of MedicineThe Methodist Hospital Research InstituteTerminated
-
Pharmacosmos A/SCompletedNon-myeloid Malignancies | Chemotherapy Induced AnaemiaIndia
-
University of PaviaFondazione Salvatore Maugeri; IRCCS Policlinico S. MatteoUnknown
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedHematologic MalignanciesUnited States
-
EMD SeronoTerminatedHaematological MalignanciesItaly, United States, Switzerland, Belgium, Germany
-
Hospices Civils de LyonUnknown
-
First Affiliated Hospital of Harbin Medical UniversityUnknownCD19-chimeric Antigen Receptor T Cells | Relapsed and/or Refractory Acute Lymphoblastic Leukemia | the Haploidentical Hematopoietic Stem Cell TransplantationChina
-
University of Colorado, DenverCompletedMalignancies | Stenosis of VaginaUnited States
-
Esanex Inc.Completed
-
PCI Biotech ASCompletedCutaneous or Sub-cutaneous MalignanciesUnited Kingdom
-
Clavis PharmaCompletedAML | Hematologic MalignanciesUnited States, United Kingdom, France, Germany, Italy, Norway
-
Zhejiang UniversityNot yet recruiting
-
Kangpu Biopharmaceuticals, Ltd.RecruitingHematological MalignanciesUnited States
-
Rhizen Pharmaceuticals SACompletedHematological MalignanciesUnited States, Georgia, Poland
-
medac GmbHCompletedHematological MalignanciesGermany, Finland, Poland, Sweden